Uzbekistan

KEY RESULTS - HIV

 

52,400 counselling and testing encounters for HIV

Source: UNDP

Women with HIV receiving ARVs to prevent mother to child transmission (2013)

Source: World Health Organization

15,900 people with HIV receiving antiretroviral therapy in (2016)

Source: UNDP

Project Summary

UNDP became principal recipient of a Global Fund grant for HIV in 2012 aimed at expanding the response to the spread of AIDS in Central Asia. The agreement supports national HIV initiatives by improving monitoring and evaluation as well as providing treatment, care, and prevention services, with a focus on those most at risk. UNDP Uzbekistan previously provided administrative and management support to the Republican AIDS Centre for the HIV component of the Global Fund programme there. In August 2010, UNDP was asked to become Principal Recipient for the Global Fund’s HIV programmes in Uzbekistan.

Strengthening National Supply Chain Management

Previously in Uzbekistan most drugs used in antiretroviral treatment were procured with Global Fund support.  In order to address sustainability of supply the government of Uzbekistan allocated 2 million USD for ARV procurement. In September 2013 the Ministry of Health and UNDP signed an agreement which envisages UNDP support to procure ARV with government allocated funding. This ensures best value for money, supply of quality assured drugs and further contributes to the strengthening of national supply chain management.

KEY RESULTS - CONTINUED

 

People living with HIV

Source: UNAIDS

Maternal and infant mortality rates

Source: World Health Organization

PORTFOLIO OVERVIEW

 

 

Disease Component

HIV

Grant

UZB-H-UNDP

Phase

Phase 1 extension

Amount

                        $33,513,271

Rating

 

 

 

Overall Grant Rating

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available